Skip to Main Content

Author Details

Nikolas von Bubnoff
University Hospital of Schleswig-Holstein
1997
133
37
PMIDPaper TitleJournal TitlePublished Year
34929747Myeloid Leukemia Involvement or Intraocular Inflammation? Histopathological Examination of a Fibrinous Anterior Chamber Membrane.Klin Monbl Augenheilkd2023
37756525Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapy.Blood2023
37488307Molecularly Stratified Treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or BCL6 Rearrangements (HGBL, NOS with MYC/BCL6).Target Oncol2023
37532709Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification.Nat Commun2023
37257194Platelets regulate ischemia-induced revascularization and angiogenesis by secretion of growth factor-modulating factors.Blood Adv2023
37423893Dose-dependent expression of GFI1 alters metabolism in the haematopoietic progenitors and MLL::AF9-induced leukaemic cells.Br J Haematol2023
36982486Development of Highly Sensitive Digital Droplet PCR for Detection of cKIT Mutations in Circulating Free DNA That Mediate Resistance to TKI Treatment for Gastrointestinal Stromal Tumor (GIST).Int J Mol Sci2023
37091981Dose-dependent effect of GFI1 expression in the reconstitution and the differentiation capacity of HSCs.Front Cell Dev Biol2023
36923431Primary refractory plasmablastic lymphoma: A precision oncology approach.Front Oncol2023
36696631Activated granulocytes and inflammatory cytokine signaling drive T-cell lymphoma progression and disease symptoms.Blood2023
36403897Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis.J Allergy Clin Immunol Pract2023
36920563An overview and a roadmap for artificial intelligence in hematology and oncology.J Cancer Res Clin Oncol2023
36879456Patient-derived xenograft mouse models to investigate tropism to the central nervous system and retina of primary and secondary central nervous system lymphoma.Neuropathol Appl Neurobiol2023
36827620Prognostic value of blood biomarkers in steroid-refractory or steroid-dependent acute graft-versus-host disease: a REACH2 analysis.Blood2023
36564535Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group.Ann Hematol2023
34772609The CIRCULATE Trial: Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation (AIO-KRK-0217).Clin Colorectal Cancer2022
35763870Gene expression-based prediction of pazopanib efficacy in sarcoma.Eur J Cancer2022
35788129Integrative molecular profiling identifies two molecularly and clinically distinct subtypes of blastic plasmacytoid dendritic cell neoplasm.Blood Cancer J2022
36358883The Glasgow Prognostic Score Predicts Survival Outcomes in Neuroendocrine Neoplasms of the Gastro-Entero-Pancreatic (GEP-NEN) System.Cancers (Basel)2022
36233057CXCR4, CXCR5 and CD44 May Be Involved in Homing of Lymphoma Cells into the Eye in a Patient Derived Xenograft Homing Mouse Model for Primary Vitreoretinal Lymphoma.Int J Mol Sci2022
34788985Mutational landscape of high-grade B-cell lymphoma with <i>MYC-</i>, <i>BCL2</i> and/or <i>BCL6</i> rearrangements characterized by whole-exome sequencing.Haematologica2022
34750506The IL-3, IL-5, and GM-CSF common receptor beta chain mediates oncogenic activity of FLT3-ITD-positive AML.Leukemia2022
34714908Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways.Blood Adv2022
34653314Early assessment of circulating tumor DNA after curative-intent resection predicts tumor recurrence in early-stage and locally advanced non-small-cell lung cancer.Mol Oncol2022
32945554Exhaustion of tumour-infiltrating T-cell receptor repertoire diversity is an age-dependent indicator of immunological fitness independently predictive of clinical outcome in Burkitt lymphoma.Br J Haematol2021
33677466Long-term safety and efficacy of givinostat in polycythemia vera: 4-year mean follow up of three phase 1/2 studies and a compassionate use program.Blood Cancer J2021
33509020Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma.Thyroid2021
33672644Systemic Inflammation and Tumour-Infiltrating T-Cell Receptor Repertoire Diversity Are Predictive of Clinical Outcome in High-Grade B-Cell Lymphoma with <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> Rearrangements.Cancers (Basel)2021
33581142Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on Mastocytosis.J Invest Dermatol2021
33800365Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center Analysis.Cancers (Basel)2021
33660007Performance of international prognostic indices in plasmablastic lymphoma: a comparative evaluation.J Cancer Res Clin Oncol2021
34500469Aggressive B-cell lymphoma cases with 11q aberration patterns indicate a spectrum beyond Burkitt-like lymphoma.Blood Adv2021
34769209Tailored Systemic Therapy for Colorectal Cancer Liver Metastases.Int J Mol Sci2021
34413471Correction: Colon and liver tissue damage detection using methylated SESN3 and PTK2B genes in circulating cell-free DNA in patients with acute graft-versus-host disease.Bone Marrow Transplant2021
34039950Genomic insights into the pathogenesis of Epstein-Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing.Blood Cancer J2021
33977163The role of family confidants and caregivers in the care of older cancer patients: Extending the concept of "shared decision-making".Health Sci Rep2021
34112699Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers.Cancer Discov2021
33346151Scoring the Risk of Having Systemic Mastocytosis in Adult Patients with Mastocytosis in the Skin.J Allergy Clin Immunol Pract2021
33430810Longitudinal analysis of cell-free mutated KRAS and CA 19-9 predicts survival following curative resection of pancreatic cancer.BMC Cancer2021
33082554Colon and liver tissue damage detection using methylated SESN3 and PTK2B genes in circulating cell-free DNA in patients with acute graft-versus-host disease.Bone Marrow Transplant2021
33149267Activating JAK-mutations confer resistance to FLT3 kinase inhibitors in FLT3-ITD positive AML in vitro and in vivo.Leukemia2021
33466775Biologically Active Tissue Factor-Bearing Larger Ectosome-Like Extracellular Vesicles in Malignant Effusions from Ovarian Cancer Patients: Correlation with Incidence of Thrombosis.Int J Mol Sci2021
32320566Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease.N Engl J Med2020
35050727Circulating Tumor DNA Allows Early Treatment Monitoring in BRAF- and NRAS-Mutant Malignant Melanoma.JCO Precis Oncol2020
31958882Impact of treatment variability and clinicopathological characteristics on survival in patients with Epstein-Barr-Virus positive diffuse large B cell lymphoma.Br J Haematol2020
32050609Requirements Analysis and Specification for a Molecular Tumor Board Platform Based on cBioPortal.Diagnostics (Basel)2020
31955503CCL5 mediates target-kinase independent resistance to FLT3 inhibitors in FLT3-ITD-positive AML.Mol Oncol2020
32047238Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study.Leukemia2020
31740811Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry.Leukemia2020
31734835Tissue factor activity on microvesicles from cancer patients.J Cancer Res Clin Oncol2020
  • 1 - 50 of 133

Recommended Authors

Haijiao Zhang
Oregon Health & Science University, Knight Cancer Institute
Career Start Year 2017
Number of shared co-authors 4
Srinivas K Tantravahi
Huntsman Cancer Institute at the University of Utah.
Career Start Year 2012
Number of shared co-authors 5
Andy Kaempf
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2011
Number of shared co-authors 3
Amanda L Christie
Dana-Farber Cancer Institute
Career Start Year 2010
Number of shared co-authors 2
Anagha Deshpande
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2009
Number of shared co-authors 0
Lina Benajiba
Universite de Paris, Inserm CIC 1427
Career Start Year 2009
Number of shared co-authors 0
Jennifer Dunlap
Oregon Health & Science University
Career Start Year 2008
Number of shared co-authors 4
Uma Borate
The Ohio State University
Career Start Year 2008
Number of shared co-authors 4
Paulo Vidal Campregher
Hospital Israelita Albert Einstein
Career Start Year 2007
Number of shared co-authors 4
Christopher A Eide
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2006
Number of shared co-authors 6
Jordi Rodon
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 0
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2006
Number of shared co-authors 5
Jamshid S Khorashad
Institute of Cancer Research
Career Start Year 2006
Number of shared co-authors 5
Anna M Eiring
Texas Tech University Health Sciences Center at El Paso
Career Start Year 2004
Number of shared co-authors 5
Jean-Baptiste Micol
INSERM U7, Universite Paris-Saclay
Career Start Year 2004
Number of shared co-authors 5
Ronan Swords
Oregon Health and Science University
Career Start Year 2004
Number of shared co-authors 3
Tara L Lin
University of Kansas Medical Center
Career Start Year 2004
Number of shared co-authors 3
Thomas Ernst
Universitatsklinikum Jena
Career Start Year 2002
Number of shared co-authors 4
Elie Traer
Oregon Health & Science University
Career Start Year 1998
Number of shared co-authors 3
Michael W Deininger
University of Utah Huntsman Cancer Institute
Career Start Year 1997
Number of shared co-authors 9
Gautam Borthakur
MD Anderson Cancer Center
Career Start Year 1992
Number of shared co-authors 5
Thomas O'Hare
Huntsman Cancer Institute, University of Utah
Career Start Year 1991
Number of shared co-authors 5
Marc M Loriaux
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 1991
Number of shared co-authors 6
Jorge Cortes
Georgia Cancer Center
Career Start Year 1991
Number of shared co-authors 12
Jerald P Radich
Fred Hutchinson Cancer Center
Career Start Year 1989
Number of shared co-authors 6
Daniel J DeAngelo
Dana-Farber Cancer Institute
Career Start Year 1989
Number of shared co-authors 8
Suzanne Kamel-Reid
Toronto General Hospital, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 3
Neil P Shah
University of California San Francisco
Career Start Year 1985
Number of shared co-authors 3
Hagop Kantarjian
The University of Texas MD Anderson Cancer Center
Career Start Year 1982
Number of shared co-authors 13
Antonio Jimeno
University of Colorado School of Medicine
Career Start Year 1974
Number of shared co-authors 0

Collaborators

Axel K??nstner
University of Lubeck
Co-authored papers 9
Jason Gotlib
Stanford University School of Medicine
Co-authored papers 8
Dietger Niederwieser
University of Leipzig
Co-authored papers 7
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Co-authored papers 5
Peter Horak
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Co-authored papers 4
Luca Malcovati
University of Pavia & S. Matteo Hospital
Co-authored papers 4
Torsten Haferlach
Taussig Cancer Institute, Cleveland Clinic
Co-authored papers 4
Frederick Klauschen
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Co-authored papers 4
Simon Kreutzfeldt
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Co-authored papers 4
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 4
Friedrich St??lzel
University Hospital TU Dresden
Co-authored papers 4
Benedikt Brors
German Cancer Research Center (DKFZ)
Co-authored papers 4
Sebastian Uhrig
National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Co-authored papers 4
Pradeep Kumar Patnana
University Munster
Co-authored papers 3
Volker Endris
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 3
Barbara Hutter
National Center for Tumor Diseases (NCT) Heidelberg
Co-authored papers 3
Olaf Neumann
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 3
Xiaoqing Xie
University Hospital Munster
Co-authored papers 3
Ulrich D??hrsen
University Hospital Essen, University of Duisburg-Essen
Co-authored papers 3
Simone Hettmer
University Medical Center Freiburg, University of Freiburg
Co-authored papers 3
Cyrus Khandanpour
University Hospital of Muenster
Co-authored papers 3
Peter Schirmacher
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 3
Daria Frank
University Hospital Muenster
Co-authored papers 3
Martin Boeker
Institute of AI and Informatics in Medicine, Technical University of Munich
Co-authored papers 3
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 2
Bertram Opalka
University Hospital Essen.
Co-authored papers 2
Michael Allg??uer
Institute of Pathology, Heidelberg University Hospital
Co-authored papers 2
Martina Kirchner
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 2
Julian Varghese
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 2
Anna-Lena Volckmar
Institut fur Pathologie, Universitatsklinikum Heidelberg
Co-authored papers 2
Release 1.2